Delivery Order SPE2DB22D6029-SPE2DB25FLVKM
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,972.27 on July 31, 2025, by the Defense Logistics Agency for TREMFYA 100 mg/ml, a pharmaceutical product used in the treatment of immunological conditions. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $8,235.87 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with a completion date of September 17, 2025. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was not subject to any set-aside...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain for the supply of TREMFYA 100 MG/ML Syringe. This firm fixed price delivery order, valued at $10,046.96, represents a non-set-aside competitive award with an ultimate completion date of July 22, 2025. The contract is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,131.01 to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 mg/ml, a pharmaceutical product. This contract, awarded on May 27, 2025, with an ultimate completion date of May 28, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,187.33 delivery order contract is for the supply of TREMFYA 100 MG/ML INJECTORML, a specialty medication. The contract has an ultimate completion date of October 29, 2024 and is a firm fixed price, delivery order contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,677.02 firm fixed-price delivery order is for the supply of TREMFYA 100 mg/mL syringes, with an ultimate completion date of October 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,944.51 delivery order is for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 17, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $60,584.28 for TREMFYA 100 mg/ml pharmaceutical product, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is fulfilling...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVKMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,255.25 by the Defense Logistics Agency (DLA) on June 30, 2025, for the supply of TREMFYA 100 mg/ml, a pharmaceutical product for federal medical procurement. The contract is classified as a Delivery Order under a Firm Fixed Price arrangement with no set-aside designation, indicating competitive award to the prime contractor. Performance of this order is scheduled to be completed by July 1, 2025, with fulfillment services provided from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support contract extending through December 2026. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, vaccines, and medical devices—to support military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp consistently fulfills federal medical supply requirements through open competition, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to meet dynamic military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 6/30/25 |